Robert F. Baltera
Vorstandsvorsitzender bei Hawkeye Therapeutics, Inc.
Profil
Mr. Robert F.
Baltera is an Independent Director at Imago BioSciences, Inc., an Executive Chairman at Trestle Biotherapeutics, Inc., a President, Chief Executive Officer & Director at Cirius Therapeutics, Inc., a Chief Executive Officer at Hawkeye Therapeutics, Inc. and an Executive Chairman at Adheron Therapeutics, Inc. He is on the Board of Directors at Inipharm, Inc., Imago BioSciences, Inc., Cirius Therapeutics, Inc., FLAP LLC, Panmira Pharmaceuticals LLC and San Diego Venture Group.
Mr. Baltera was previously employed as an Independent Director by Frazier Lifesciences Acquisition Corp., an Executive Chairman by Mavupharma, Inc., a Chief Executive Officer & Director by Laguna Pharmaceuticals, Inc., an Independent Director by Xencor, Inc., an Independent Director by Organovo Holdings, Inc., a Chief Executive Officer by Amira Pharmaceuticals, Inc., a Vice President-Corporate & Contract Manufacturing by Amgen, Inc., and a Trustee by Keck Graduate Institute of Applied Life Sciences.
He also served on the board at Organovo, Inc., Aravive Biologics, Inc. and Arcturus Therapeutics, Inc.
He received his undergraduate degree from The Pennsylvania State University, a graduate degree from The Pennsylvania State University and an MBA from UCLA Anderson School of Management.
Aktive Positionen von Robert F. Baltera
| Unternehmen | Position | Beginn |
|---|---|---|
Panmira Pharmaceuticals LLC
 Panmira Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Vorsitzender | - |
FLAP LLC
 FLAP LLC Pharmaceuticals: OtherHealth Technology FLAP LLC provides licensing and royalty services for medicines. The company was founded in 2011 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Hawkeye Therapeutics, Inc.
 Hawkeye Therapeutics, Inc. BiotechnologyHealth Technology Hawkeye Therapeutics, Inc. licenses and develops assets from pharmaceutical companies. The company is headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.01.2016 |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.03.2017 |
Inipharm, Inc.
 Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Inipharm, Inc. provides health care services. The company was founded by Brian Farmer and Mike Gallatin in 2018 and is headquartered in Bellevue, WA. | Direktor/Vorstandsmitglied | 11.11.2020 |
Trestle Biotherapeutics, Inc.
 Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Gründer | 01.04.2020 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Berater | 01.01.2022 |
Ehemalige bekannte Positionen von Robert F. Baltera
| Unternehmen | Position | Ende |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.01.2023 |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Robert F. Baltera
| The Pennsylvania State University | Graduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 17 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease. | Health Technology |
Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Health Technology |
Organovo, Inc.
 Organovo, Inc. Medical/Nursing ServicesHealth Services Organovo, Inc. develops and supplies pharmaceutical products. It focuses on delivering human tissue printing technology and creating tissue on demand for research and surgical applications. The firm helps physicians and researchers fulfill the promise of regenerative medicine by overcoming problems in cardiovascular medicine, medical research and transplant medicine. The company was founded by Eric Michael David, Andras Forgacs, Gabor Forgacs and Keith Murphy in 2007 and is headquartered in San Diego, CA. | Health Services |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
San Diego Venture Group
 San Diego Venture Group Financial ConglomeratesFinance San Diego Venture Group operates as a non-profit organization that engages in the funding of start up companies. it focuses on the provision of support to the venture capital eco-system. It serves entrepreneurs, venture capitalists, community leaders, and business advisors. The company was founded in 1986 and is headquartered in San Diego, CA. | Finance |
Laguna Pharmaceuticals, Inc.
 Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. | Health Technology |
FLAP LLC
FLAP LLC Pharmaceuticals: OtherHealth Technology FLAP LLC provides licensing and royalty services for medicines. The company was founded in 2011 and is headquartered in San Diego, CA. | Health Technology |
Panmira Pharmaceuticals LLC
Panmira Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA. | Health Technology |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
Hawkeye Therapeutics, Inc.
Hawkeye Therapeutics, Inc. BiotechnologyHealth Technology Hawkeye Therapeutics, Inc. licenses and develops assets from pharmaceutical companies. The company is headquartered in San Diego, CA. | Health Technology |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Health Technology |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Health Technology |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Inipharm, Inc. provides health care services. The company was founded by Brian Farmer and Mike Gallatin in 2018 and is headquartered in Bellevue, WA. | Health Technology |
Frazier Lifesciences Acquisition Corp.
 Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Frazier Lifesciences Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on October 7, 2020 and is headquartered in Seattle, WA. | Finance |
Trestle Biotherapeutics, Inc.
Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Commercial Services |
